Ryan Merrell

1.7k total citations
35 papers, 261 citations indexed

About

Ryan Merrell is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ryan Merrell has authored 35 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 13 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ryan Merrell's work include Glioma Diagnosis and Treatment (28 papers), Cancer Treatment and Pharmacology (10 papers) and Brain Metastases and Treatment (8 papers). Ryan Merrell is often cited by papers focused on Glioma Diagnosis and Treatment (28 papers), Cancer Treatment and Pharmacology (10 papers) and Brain Metastases and Treatment (8 papers). Ryan Merrell collaborates with scholars based in United States, Netherlands and Australia. Ryan Merrell's co-authors include David A. Reardon, Lisa Roberts-Rapp, Erica Gomez, Priya Kumthekar, Hui Gan, Martin J. van den Bent, Andrew B. Lassman, Andrew M. Scott, Nina A. Paleologos and Hao Xiong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Ryan Merrell

34 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Merrell United States 10 146 89 60 59 51 35 261
Luc Verbeke Belgium 8 158 1.1× 85 1.0× 35 0.6× 66 1.1× 46 0.9× 19 305
John Floyd United States 12 89 0.6× 74 0.8× 47 0.8× 76 1.3× 47 0.9× 39 307
Carlos Mesía Spain 7 99 0.7× 72 0.8× 35 0.6× 61 1.0× 58 1.1× 14 215
María Ángeles Vaz Salgado Spain 9 122 0.8× 125 1.4× 26 0.4× 101 1.7× 62 1.2× 44 354
E. Cohen-Jonathan Moyal France 7 239 1.6× 98 1.1× 62 1.0× 108 1.8× 81 1.6× 25 355
Zhiyong Qin China 9 146 1.0× 52 0.6× 40 0.7× 46 0.8× 101 2.0× 19 290
Angela Zacher Germany 3 197 1.3× 65 0.7× 38 0.6× 41 0.7× 119 2.3× 3 270
Alberto Pïcca France 9 189 1.3× 100 1.1× 45 0.8× 92 1.6× 81 1.6× 27 339
Enrico C. Lallana United States 7 236 1.6× 137 1.5× 36 0.6× 87 1.5× 44 0.9× 8 356
Linbo Cai China 10 113 0.8× 117 1.3× 37 0.6× 165 2.8× 103 2.0× 75 337

Countries citing papers authored by Ryan Merrell

Since Specialization
Citations

This map shows the geographic impact of Ryan Merrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Merrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Merrell more than expected).

Fields of papers citing papers by Ryan Merrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Merrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Merrell. The network helps show where Ryan Merrell may publish in the future.

Co-authorship network of co-authors of Ryan Merrell

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Merrell. A scholar is included among the top collaborators of Ryan Merrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Merrell. Ryan Merrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merrell, Ryan, Patrick Y. Wen, Deborah Forst, et al.. (2024). Randomized phase IIb trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas.. Journal of Clinical Oncology. 42(16_suppl). TPS2100–TPS2100. 2 indexed citations
2.
Lyne, Séan, David J. Voce, Vinai Gondi, et al.. (2024). A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma. Neuro-Oncology Advances. 6(1). vdae014–vdae014. 4 indexed citations
3.
Robison, Ryan K., Jie Hu, Saikat Sengupta, et al.. (2023). Optimization of the flip angles of narrow‐band editing pulses in J‐difference edited MRS of lactate at 3T. Magnetic Resonance in Medicine. 91(3). 886–895.
4.
Merrell, Ryan, et al.. (2021). Standardizing Care of Neuro-oncology Patients Using a Customized Electronic Medical Record Toolkit. SHILAP Revista de lepidopterología. 5(3). 625–634. 1 indexed citations
5.
Dresser, Laura, et al.. (2020). Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis. Scientific Reports. 10(1). 17960–17960. 15 indexed citations
6.
Edelman, Robert R., et al.. (2020). Twofold improved tumor-to-brain contrast using a novel T1 relaxation-enhanced steady-state (T 1 RESS) MRI technique. Science Advances. 6(44). 9 indexed citations
7.
Gan, Hui, David A. Reardon, Andrew B. Lassman, et al.. (2017). Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma. Neuro-Oncology. 20(6). 838–847. 57 indexed citations
8.
Lassman, Andrew B., Martin J. van den Bent, Hui Gan, et al.. (2017). Efficacy analysis of ABT-414 with or without temozolomide (TMZ) in patients (pts) with EGFR-amplified, recurrent glioblastoma (rGBM) from a multicenter, international phase I clinical trial.. Journal of Clinical Oncology. 35(15_suppl). 2003–2003. 6 indexed citations
9.
Lassman, Andrew B., Hui Gan, Peter Ansell, et al.. (2017). P09.25 Identifying the correct patient (pt) population for ABT414: biomarker assays for epidermal growth factor receptor (EGFR) in pts with glioblastoma (GBM). Neuro-Oncology. 19(suppl_3). iii75–iii75. 2 indexed citations
10.
Lassman, Andrew B., Martin J. van den Bent, Hui Gan, et al.. (2016). Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM). Annals of Oncology. 27. vi103–vi103. 2 indexed citations
11.
12.
Roberts-Rapp, Lisa, Peter Ansell, И. А. Соколова, et al.. (2015). 28PD Identifying the correct patient (pt) population for ABT-414: Biomarker assays for epidermal growth factor receptor (EGFR) in pts with glioblastoma (GBM). Annals of Oncology. 26. ix8–ix8. 2 indexed citations
13.
Scott, Andrew M., Lisa Roberts-Rapp, Hui Gan, et al.. (2015). ATNT-02DETERMINANTS OF RESPONSES AND RESISTANCE TO ABT-414: RESULTS OF NEXT-GENERATION SEQUENCING. Neuro-Oncology. 17(suppl 5). v10.2–v10. 2 indexed citations
14.
Gan, Hui, Kyriakos P. Papadopoulos, Lisa Fichtel, et al.. (2015). Phase I study of ABT-414 mono- or combination therapy with temozolomide (TMZ) in recurrent glioblastoma (GBM).. Journal of Clinical Oncology. 33(15_suppl). 2016–2016. 17 indexed citations
15.
Puduvalli, Vinay K., Jing Wu, Ying Yuan, et al.. (2015). Brain Tumor Trials Collaborative Bayesian Adaptive Randomized Phase II trial of bevacizumab plus vorinostat versus bevacizumab alone in adults with recurrent glioblastoma (BTTC-1102).. Journal of Clinical Oncology. 33(15_suppl). 2012–2012. 9 indexed citations
16.
Nicholas, M. Kelly, Rimas V. Lukas, Nicholas A. Vick, et al.. (2013). Final results of a single-arm phase II study of bevacizumab and temozolomide following radiochemotherapy in newly dignosed adult glioblastoma patients.. Journal of Clinical Oncology. 31(15_suppl). 2076–2076. 1 indexed citations
17.
Wong, Ricky H., Beenu Thakral, William Watkin, et al.. (2013). Intracranial, intra-axial metastatic giant cell tumor of bone: Case report and review of literature. Clinical Neurology and Neurosurgery. 117. 40–43. 3 indexed citations
18.
Merrell, Ryan. (2012). Brain Tumors. Disease-a-Month. 58(12). 678–689. 9 indexed citations
19.
Paleologos, Nina A. & Ryan Merrell. (2012). Anaplastic Glioma. Current Treatment Options in Neurology. 14(4). 381–390. 10 indexed citations
20.
Didlake, Ralph, et al.. (1987). Effects of a combined antigen-cyclosporine regimen in four transplantation models.. PubMed. 19(1 Pt 2). 1281–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luc Verbeke Breakdown of academic impact, for papers by John Floyd Breakdown of academic impact, for papers by Carlos Mesía Breakdown of academic impact, for papers by María Ángeles Vaz Salgado Breakdown of academic impact, for papers by E. Cohen-Jonathan Moyal Breakdown of academic impact, for papers by Zhiyong Qin Breakdown of academic impact, for papers by Angela Zacher Breakdown of academic impact, for papers by Alberto Pïcca Breakdown of academic impact, for papers by Enrico C. Lallana Breakdown of academic impact, for papers by Linbo Cai
Rankless by CCL
2026